Pharmaceuticals UltraSector ProFund Investor
Pharmaceuticals UltraSector ProFund Investor (PHPIX)
The Pharmaceuticals UltraSector ProFund Investor (PHPIX) is a mutual fund that focuses on investing in companies within the pharmaceutical industry. This fund aims to provide investors with exposure to the fast-growing and ever-evolving pharmaceutical sector, which includes companies involved in the research, development, and production of drugs and medications. With a ticker symbol of PHPIX, this mutual fund offers investors the opportunity to potentially benefit from the growth and innovation in the pharmaceutical industry.
PHPIX Mutual Fund Chart & Stats
- Previous Close
- $42.68
- Sub-Category
- Sector-Specific
- Total Liabilities
- $7.78M
- Expense Ratio
- 1.78%
- Holding Count
- 64
- Brand
- Profunds
- Category
- Equity
- Total Assets
- 16.35M
- Shares Outstanding
- N/A
- 52-Week Range
- $29.96 - $50.67
PHPIX Mutual Fund News
Nuvation Bio’s safusidenib shows benefits in Phase 2 IDH1-mutant glioma study
Nuvation Bio (NUVB) announced new long-term follow-up data from the Phase 2 study of investigational safusidenib in patients with chemotherapy- and radiotherapy-naive grade 2 IDH1-mutant glioma. The data demonstrated durable
Amylyx announces Phase 3 Lucidity trial met prespecified primary endpoint
Amylyx (AMLX) Pharmaceuticals will present the results from the 16-week double-blind treatment period of the Phase 3 Lucidity clinical trial of avexitide, an investigational, first-in-class glucagon-like peptide-1 receptor antagonist, in
Top 10 Holdings
| Name | Weight % |
|---|---|
| CRNXCRINETICS PHARMACEUTICALS INC | 2.60% |
| MBXMBX Biosciences, Inc. | 2.28% |
| ATAIATAIBECKLEY INC | 2.03% |
| DFTXDefinium Therapeutics, Inc. | 2.00% |
| AMLXAmylyx Pharmaceuticals, Inc. | 1.62% |
| ELVNEnliven Therapeutics, Inc. | 1.59% |
| CORTCorcept Therapeutics | 1.57% |
| ALMSAlumis Inc. | 1.51% |
| NUVBNuvation Bio Inc | 1.48% |
| TRVITrevi Therapeutics | 1.46% |
| Total | 18.13% |
Recently Viewed
No data currently available






